UBT SRL (Umbria Bioengineering Technologies) was founded in 2015 as an innovative startup and academic spin-off of the Department of Physics and Geology (FISGEO) of the University of Perugia, Italy. UBT (benefit company) is a biomedical company which develops and commercialises a portfolio of innovative medical imaging devices based on cutting-edge microwaves technology instead of dangereous ionizing radiation (X-Rays). UBT has so far developed the following patented products:
– MammoWave (TRL 9): a new device for detecting breast lesions.
– BrainWave (TRL 6): is a novel device for brain stroke detection and classification.
– LungWave (TRL 4): s a novel device for lung lesions detection and monitoring.
UBT has all the scientific, technical and managerial skills to design and clinically validate microwave imaging devices, introducing them to the market.
UBT has successfully applied to many European Horizon H2020 calls, obtaining significant grants (over 2 million euros) under the SME Instrument Phase 1, SME Instrument Phase 2, Marie Skłodowska-Curie Research and Innovation Staff Exchange, FET-Future Emerging Technologies
Since 2017, UBT has been collaborating with London South Bank University in the UK, where it has an office and has sponsored scholarships (PhD and post-PhD). In December 2020, UBT opened a UK subsidiary (company number 13096679).
UBT SRL team has multidisciplinary and synergistic skills, with a scientific, clinical, business, commercial and management background.
Graduated in Informatics at Bicocca University, Milano, with an Executive Master in SME Management at Università Cattolica, Milano, he is currently the Head of R & D of the Radiology Division at Digitec, Lecco, Italy. He is an expert in software for medical imaging, management of acquisition functions, real-time processing, post-processing, measurements, distribution in DICOM hospital network (Digital Imaging and COmmunications in Medicine) of related images.
Graduated in Telecommunications Engineering from the University of Pisa with a Master at King’s College (UK), Ph.D. degree in Information Engineering from the University of Pisa, Post Ph.D. at University of Oxford through a Marie Curie Intra European Fellowships for Career Development, Seventh Research Framework Programme. Gianluigi matured a solid experience in the applied electromagnetics and microwave imaging for medical application (he is also the coordinator the Radio Frequency laboratory of Imago7 Foundation, Pisa). He authored more than 80 journal and conference papers and he is co-lecturer of Electromagnetics for Medical Applications at Biomedical Engineering, University of Pisa He is the scientist who studied the theory of MammoWave technology disseminated via numerous international conferences and scientific papers. He is the inventor of the patented microwave apparatus (Apparatus for testing the integrity of mammary tissues) and founder of UBT-Umbria bioengineering technologies.
Navid Ghavami received the B. Eng degree in Electrical and Electronic Engineering from King’s College and a Ph.D. degree from the University of Oxford. During his PhD and post-doc years, he worked on developing microwave imaging methods with potential applications on cancer detection. Together with Gianluigi Tiberi, he studied the theory of MammoWave technology disseminated via numerous international conferences and scientific papers. Winner of several prizes, he was research associate at King’s College, London. He now joined UBT UK division as senior researcher in imaging and algorithm development
Mario Badia got the Bachelor Degree in Telecommunications and Electronics Engineering at Universidad de Oriente, Cuba, in 2016, with focus on software engineering, machine learning, digital signal processing and computer networks. Next, he matured a solid experiences as telecommunication engineer (ETECSA, Cuba) and as Software Developer (MICRA SOFTWARE E SERVICES Srl, Italy). In 2091, he joined UBT Srl, working in the development of radio-frequencies integrated solutions for biomedical applications, signal processing, data analysis using machine learning algorithms. His software skill includes: Python, Machine Learning, Web develop, C#, JAVA, MATLAB, Flutter.
Graduated in Physics at the Department of Physics and Geology (FISGEO) of the University of Perugia, she did her final project at the Hospital of S.Maria della Misericordia, Perugia, working on the analysis and processing of radiological and MR images. In November 2017 Alessandra joined the scientific team of UBT, managing clinical trial and regulatory.
Graduated in Physics at the Department of Physics and Geology of the University of Perugia in 2017, he received a Ph.D. in Physics from University of Padova in 2020. During his Ph.D. , Dr. Papini worked on modelization of black hole solutions in the context of String Theory, specializing in solving (numerically and analytically) non-linear differential equations and in analyzing the various black hole parameters by using various data analysis techniques. From July 2021, Lorenzo started working with UBT team, focussing on data analysis and development of machine learning algorithms to be applied to the collected data.
Graduated in Biology at the University of Pisa, Italy, with experimental thesis/clinical research at CNR-Pisa Genetics Department, Stefano started his career path in the Italian healthcare market where he obtained a vast level of professional growth through the management of complex businesses. He has a deep understanding of both the pharmaceutical market (15 years with Pfizer, Italy, where he covered various managerial roles) and the medical device market (6 Years in Philips Healthcare Italy, where he covered the role of Country Manager).
Stefano is now the UBT Director of Commercial Operations in Italy; he is creating the commercial structure in charge of developing the Italian market through a direct sales approach.
Graduated in Physics at the Department of Physics of the University of Tehran, she got a Master of Science (MSC) degree with first class in Electrical & Electronic Engineering, Biomedical Engineering, and a Ph.D. at London South Bank University, London (UK). Her research area is in the optimization of the microwave apparatus for breast cancer detection and its extension to other diagnostic applications, such as bone lesions detection and lung imaging.
Renier Perez earned a degree in Computer Science Engineering from the University of Informatics Sciences in Havana, Cuba, in 2012, with a focus on Software Engineering and Artificial Intelligence. He has since served as a Senior Specialist in Computer Science (XETID, Cuba), a Software Quality Control Engineer and DevOps Engineer (OptimalBit LLC, Belarus, remote), and a Backend Developer (Soldev, France, remote).
He has now joined UBT and is currently pursuing a master's degree in Artificial Intelligence at the University of Calabria in Italy. His software skills include: Python, machine learning, web development, C#, PHP, Angular, Flutter, and data analysis.
Moein Movafagh received MSc in Electrical engineering from KNTU, Iran, and is currently studying for a Ph.D. at London South Bank University, UK, focussed on microwave imaging and artificial intelligence for stroke and breast applications. During his MSc, he worked on FMCW radar imaging and improving the SNR of the image created by the synthetic aperture radar (SAR) method. Besides, he worked on the automotive radar with a focus on mitigating interference with collaboration with Infineon; he published papers and filed a patent.
Subhra Prakash Rana received Bachelor of Technology (B.TECH) in Civil Engineering from BPUT UNIVERSITY ODHISHA, INDIA, and Master of Design (M.DES) in Industrial Design from VIT UNIVERSITY, VELLORE, INDIA (2021). He has expertise in problem solving and Computer Aided Design (CAD) to create high-quality drafting experience with Bill of Materials (BOM) in SOLIDWORKS. He is proficient in using Key-Shot for 3D renderings and in developing FDM 3D printers from scratch for rapid prototyping.
He joined UBT SRL acting as Intern Product Designer.
Gianmarco Palomba got the Bachelor Degree in Biomedical Engineering at University of Naples “Federico II”, Italy, in 2017. He concluded his study at University of Padua, Italy where he graduated in Bioengineering, in 2021, choosing a transversal study path in different biomedical sectors such as: processing and analysis of biomedical data, clinical engineering, mechanics of materials and neurosciences. His first professional experince was in Rome, with LB Servizi per le Aziende Srl. Here, he worked as laboratory engineer-technician for the dosimetric analysis department. In early 2023, Gianmarco joined the UBT research team holding the data analyst role to perform quality control and performance assessment.
Sabatino Tiberi (degree in economics and Master degree at ISTAO- Istituto Adriano Olivetti) has held managing position in several large Italian companies: Marketing manager at Vela SpA (GE.P.I Groups), General Manager at Agnano confezioni SpA (GE.P.I. Groups), General Manager at Calzaturificio Umbro (Gruppo IGI / Primigi) gaining a solid managerial expertise in business administration and marketing. Since 2015, he is CEO at UBT and is fully committed to manage the business development of MammoWave.
Ronchini has a consolidated and extensive experience in the pharmaceutical industry, especially in the area of sales and marketing. Giorgio has been working at leading medical and pharmaceutical companies, among which are Pfizer, Pharmacia Italia, Abbott Italia, Boehringer, Carlo Erba.
Dr Michele Duranti, MD, specialized in Radiodiagnostics and Imaging Science at University of Perugia (1993) and currently director at Radiology department at the Hospital of S.Maria della Misericordia (Perugia Hospital), is the Principal Investigator of the feasibility clinical trials conducted by UBT. In this context, he leads in Perugia a team of four physicians himself; Dr Andrea Saracini; Dr Eleonora Vannini; Dr Simonetta Ercolani) actively involved in the ongoing clinical trials, and they are also contributing with their unique insights to UBT business and scientific project. He is also coordinating the activity of Dr. Riccardo Loretoni, which is performing MammoWave clinical trials at Foligno Hospital, Italy.
Full professor in Enterprise funding at the Department of Economics of University of Perugia. He is delegate of the University’s rector for the Technology Transfer activity. He has ten years of experience in innovation and incubation of start-ups and spin-off companies coming from breakthrough research. He is member of the directors board of PNICube, Association of the Incubators and of the Italian Academic Business Plan Competitions, of which he was previously President and Vice-President. He is author of more than 30 scientific publications on finance, bank and marketing.
Top Manager at Philips for many years, Perry is an expert of the Market of Medical Imaging Devices. Perry now works as a consultant and as a coach on behalf of EIC/H2020. In this context, Perry assisted UBT during SMEINST Phase1 and Phase2 projects, supporting it in the analysis of commercial strategies. Perry continues to support UBT as a consultant.
Raúl is a Market Access Consultant and a Business Coach provided by EIC/H2020, with strong experience in the area of Healthcare including internationalization, strategy, business development and investment advice. Specifically, he is working with Healthcare and Medical Start-up up and SMEs with innovative Technologies.
Raúl assisted UBT during SMEINST Phase1 and Phase2 projects, and now continues to support UBT as a consultant, always in the context of internationalization, strategy, business development and investment advice.
Thanks to the MammoScreen project, which was awarded funding under HORIZON-MISS-2021-CANCER-02-01, UBT Srl is a partner in a consortium comprising (in addition to UBT): Toscana Life Sciences Foundation (Italy); London South Bank University (UK); ELAROS 24/7 Limited (UK); Servicio de Salud de Castilla-La Mancha (Spain); Scuola IMT Alti Studi Lucca (Italy); EVITA – Cancro Hereditário (Portugal). For more details: https://mammoscreenproject.eu/
Thanks to the RadioSpin project, which was awarded under the H2020-FETPROACT program, UBT Srl is a partner in a consortium comprising (in addition to UBT): the University of Bordeaux (France); the National Center for Scientific Research (CNRS) (France); the International Iberian Nanotechnology Laboratory (INL) (Portugal); Thales (France); and Eurida Research (Austria). For more details: https://www.radiospin.eu/
Thanks to the ROVER project, which was awarded under the H2020 MSCA-RISE-2019 program, UBT Srl is a partner in a consortium comprising (in addition to UBT): the University of Oulu; the University of Florence; London South Bank University; Oslo University Hospital; Elaros 24/7 Limited; Yokohama National University; University of Technology Sydney; Asian Institute of Technology; Worcester Polytechnic Institute; University of Oulu Research Institute in Japan; and the University of Nebraska-Lincoln. For more details: https://www.rover2020.eu
Thanks to several projects awarded under the European Union, three clinical trials (one of which is still ongoing) related to the clinical validation of MammoWave have been launched at the Hospital Universitario de Toledo (Spain). The Hospital Universitario de Toledo is also a partner in the MammoScreen project.
Thanks to several projects awarded under the European Union, three clinical trials (one of which is still ongoing) related to the clinical validation of MammoWave have been launched at the San Martino Polyclinic Hospital in Genoa, Italy. In particular, the San Martino Polyclinic Hospital serves as the Italian coordinating center for the clinical study of the MammoScreen project.
UBT Srl activated Industry Part Funded PhD and Matched Funded Post-PhD with the Centre for Bioengineering (former BiMEC), at London South Bank University (LSBU), UK, focused on the optimization of the microwave apparatus for breast cancer detection and its extension to other diagnostic applications, and on Artificial Intelligence-AI.
Imago 7 Foundation is a consortium for scientific research in the field of magnetic resonance(MR); it is equipped the first and only 7.0 Tesla MR system in Italy. it is equipped the first and only 7.0 Tesla MR system in Italy. it is equipped the first and only 7.0 Tesla MR system in Italy.
DIGITEC Srl, leader in software for medical imaging and digital innovation, operates in the radiology sector, designing and customising hardware and software systems capable of acquiring, processing and transferring medical images.
This partnership concerns the risk assessment for electromagnetic fields radiated by medical devices such as electrosurgical-knifeand magneto-therapy apparatus. In addition, MammoWave clinical trials have been activated at Foligno Hospital.
This partnership concerns the definition of dedicated protocols for the measurements of electromagnetic fields, in working environments and hospital environments.
The first MammoWave clinical trialshave been activated at Perugia Hospital “Azienda Ospedaliera S. Maria della Misericordia”. Feasibility clinical trials successfully ended in 2020.
Do not hesitate to contact us. We will be happy to inform you about our innovative medical devices
